RUA Life Sciences plc (AIM:RUA)
London · Delayed Price · Currency is GBP · Price in GBX 24.67
+4.17 (20.33%)
May 8, 2026, 4:27 PM GMT
RUA Life Sciences Market Cap
RUA Life Sciences has a market cap or net worth of 12.72 million as of May 8, 2026. Its market cap has increased by 74.47% in one year.
Market Cap
12.72M
Enterprise Value
10.31M
Revenue
4.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.67
Market Cap Chart
Since February 26, 1997, RUA Life Sciences's market cap has decreased from 23.82M to 12.72M, a decrease of -46.59%. That is a compound annual growth rate of -2.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 12.72M | 46.43% |
| Dec 31, 2025 | 8.69M | 27.27% |
| Dec 31, 2024 | 6.83M | 11.68% |
| Dec 29, 2023 | 6.11M | -43.19% |
| Dec 30, 2022 | 10.76M | -35.33% |
| Dec 31, 2021 | 16.64M | -50.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.41B |
| GSK plc | 74.85B |
| Haleon | 29.72B |
| Smith & Nephew | 9.54B |
| Cambridge Cognition Holdings | 16.29M |
| genedrive | 15.25M |
| Fusion Antibodies | 15.00M |
| IXICO | 14.99M |